Detection of epidermal growth factor receptor gene mutations in non-small cell lung cancer using bi-loop probe specific primer quantitative PCR

Chinese Journal of Pathology

Volumn 40, Issue 10, 2011, Pages 667-670

  Wang, Li Shuai ^a   Zhang, Yu ^b   Lu, Xiao Jun ^b   Lu, Hua Jun ^b   Zhou, Lin ^b   Wang, Yong Sheng ^b   Deng, Lei ^b   Huang, Mei Juan ^b   Peng, Feng ^b   Wang, Jin ^b   Ren, Li ^b   Hou, Mei ^b   Li, Lu ^b   Xu, Yong ^b   Ying, Bin Wu ^b   Lu, You ^b  

^a SICHUAN UNIVERSITY   (China)

^b NONE

Author keywords

Carcinoma, non small cell lung; Polymerase chain reaction; Receptor, epidermal growth factor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADENOCARCINOMA; AGED; ARTICLE; EXON; FEMALE; GENE DELETION; GENETICS; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; METHODOLOGY; MIDDLE AGED; MUTATION; MUTATION RATE; PATHOLOGY; PLEURA EFFUSION; PROTO ONCOGENE; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SMOKING;

ADENOCARCINOMA; AGED; CARCINOMA, NON-SMALL-CELL LUNG; EXONS; FEMALE; GENE DELETION; GENES, ERBB-1; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; MUTATION RATE; PLEURAL EFFUSION, MALIGNANT; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR; SENSITIVITY AND SPECIFICITY; SEX FACTORS; SMOKING;

EID: 80555153647     PISSN: 05295807     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0529-5807.2011.10.006     Document Type: Article

References (13)

1. Jemal A, Thomas A, Murray T, et al. Cancer statistics,2002. CA Cancer J Clin,2002, 52(1) :2347.
2. Herbst RS, Heymaeh JV, Lippman SM. Lung Cancer. N Engl J Med,2008,359(13) :1367-1380.
3. Lynch TJ, Bell DW, Sordela R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of nonsmall cell lung caucer to gefitinib. N Engl J Med,2004,350(21) : 2129-2139. (Pubitemid 38637993)
4. Mok TS, Wu YL, Thongprasert S,et al. Gefitinib or CarboplatinPaclitaxel in pulmonaryn adenocarcinoma. N Engl J Med, 2009, 361(10) 947-957.
5. Paez JG, Janne PA, Lee JC, et al. EGFR mutations in lung cancer : correlation with clinical response to gefitinib therapy. Science, 2004,304(5676) :1497-1500. (Pubitemid 38720929)
6. Pao W, Mdler V, Zakowski M, et al. EGFR receptor gene mutations are common in lung cancers from " never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci U S A,2004,101 (36) 3306-13311.
7. Rosell R, Moran T, Queratt C, et al. Screening for epidermal growth factor receptor mutations in lung cancer. N Engl J Med, 2009, 361(10): 958-967.
8. Zhang XZ, Chang A. Somatic mutations of the epidermal growth factor receptor and non-small-cell lung cancer. J Med Genet, 2007,44(3) :166-172. (Pubitemid 46580525)
9. Gridelli C. Treatment of advanced non-small-cell lung cancer in the elderly: From best supportive care to the combination of plalinbased chemotherapy and targeted therapies. J Clin Oncol, 2008, 26(1):13-15.
10. Kimura H, Fujiwara Y, Sone T, et al. EGFR mutation status in tumour-derived DNA from pleura leffusion fluid is a practical basis for predicting the response to gefitinib. Br J Cancer, 2006, 95 (10):1390-1395. (Pubitemid 44760091)
11. Wu SG,Cow CH, Yu CJ,et al. Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma. Eur Respir J,2008, 32(4) :924-930.
12. Park S, Holmes-Tisch AJ, Cho EY. Discordance of molecular biomarkers associated with epidermal growth factor receptor pathway between primary tumors and lymph node metastasis in non-small cell lung cancer. J Thorac Oncol, 2009,4 (7) :809815.
13. Gow CH, Chang YL, Hsu YC, et al. Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naïve non-small-cell lung cancer. Ann Oncol, 2009,20(4) :696-702.